首页 | 本学科首页   官方微博 | 高级检索  
     

几何不确定性鲁棒优化在肝癌立体定向放疗中的应用
引用本文:刘登洪,王雪桃,钟仁明. 几何不确定性鲁棒优化在肝癌立体定向放疗中的应用[J]. 中国医学物理学杂志, 2022, 0(2): 162-168. DOI: DOI:10.3969/j.issn.1005-202X.2022.02.006
作者姓名:刘登洪  王雪桃  钟仁明
作者单位:四川大学华西临床医学院(华西医院)肿瘤中心放疗科(生物治疗国家重点实验室), 四川 成都 610041
基金项目:四川大学华西医院临床研究孵化项目(2021HXFH029);四川省科技厅重点研发项目(2021YFQ0065)。
摘    要:目的:分析基于几何不确定性的鲁棒优化计划对肝癌立体定向放疗(SBRT)剂量分布的影响。方法:选取12例肝癌SBRT患者,对每例制作3个调强计划:①基于PTV(ITV-PTV 5 mm)的常规优化(PTV-Based Plan);②基于ITV非均匀几何不确定性(本中心计算的不确定性值:进出方向7 mm,左右和前后方向4 mm)的鲁棒优化(Robust Planactual);③基于ITV均匀5 mm几何不确定性的鲁棒优化(Robust Plan5 mm)。所有计划都以95%的PTV满足处方剂量作为目标,以等中心均匀偏移4、5、7 mm计算扰动剂量评估鲁棒性。结果:计划①②③的均匀性指数(HI)分别为0.083±0.027、0.099±0.035、0.096±0.026,不具有统计学意义;计划①②③的适形性指数(CI)分别为0.98±0.02、1.02±0.05、1.00±0.04,计划②③相对于计划①的CI具有统计学意义。计划③的正常肝组织平均受量和V2500相对于计划①②分别下降了4.1%、2.5%和5.4%、3.0%,...

关 键 词:肝癌  立体定向放疗  鲁棒优化  几何不确定性

Application of geometric uncertainty-based robust optimization in stereotactic body radiotherapy for liver cancer
LIU Denghong,WANG Xuetao,ZHONG Renming. Application of geometric uncertainty-based robust optimization in stereotactic body radiotherapy for liver cancer[J]. Chinese Journal of Medical Physics, 2022, 0(2): 162-168. DOI: DOI:10.3969/j.issn.1005-202X.2022.02.006
Authors:LIU Denghong  WANG Xuetao  ZHONG Renming
Affiliation:Department of Radiotherapy (State Key Laboratory of Biotherapy), Cancer Center, West China School of Medicine (West China Hospital), Sichuan University, Chengdu 610041, China
Abstract:Objective To analyze the effects of robust optimization plan based on geometric uncertainty on the dose distribution of stereotactic body radiotherapy(SBRT)for liver cancer.Methods Twelve patients treated by SBRT for liver cancer were enrolled in the study.For each case,3 different kinds of plans were designed by different optimization methods,including①conventional optimization(PTV-Based Plan)based on PTV(ITV-PTV _(5 mm)),②robust optimization(Robust Planactual)based on non-uniform geometric uncertainty for ITV(the uncertainties calculated by our center were 7 mm in superior-inferior direction,4 mm in medial-lateral and anterior-posterior directions),③robust optimization(Robust Plan5 mm)based on uniform geometric uncertainty of 5 mm for ITV.All plans were based on the target that 95%ITV met the prescribed dose,and the perturbation dose was calculated with uniform uncertainties of 4,5,7 mm from the isocenter to evaluate the robustness.Results The homogeneity index of plans①②③was 0.083±0.027,0.099±0.035 and 0.096±0.026,respectively,without statistical significance;and the conformity index of plans②③was 1.02±0.05,1.00±0.04,significantly different from that of plan①which was 0.98±0.02.Compared with those in plans①②,the average dose to normal liver tissues in plan③was decreased by 4.1%and 2.5%(P=0.034,P=0.021),and V2500was decreased by 5.4%and 3.0%(P=0.004,P=0.004),respectively.The average dose to normal liver tissue and V2500in plan②were not statistically different from those in plan①(P=0.308 and P=0.182),but decreased by 1.6%and 2.5%.For robustness,the differences in dose-volume histogram bandwidth(DVHBW)of 5 mm-D99%,5 mm-D98%,5 mm-D95%in plans②③were smaller than those in plan①.With the increase of setup uncertainty,the difference in DVHBW became greater.Conclusion In liver SBRT,robust optimization can optimize target dose distribution.Even if the setup uncertainty increases,it can still ensure the dose coverage of ITV,without increasing the irradiation dose to normal tissues.
Keywords:liver cancer  stereotactic body radiotherapy  robust optimization  geometric uncertainty
本文献已被 维普 等数据库收录!
点击此处可从《中国医学物理学杂志》浏览原始摘要信息
点击此处可从《中国医学物理学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号